Table of Content

1. Introduction

2. Research Methodology

3. Executive Summary


4. United States Biopsy Market & Volume

4.1 Market & Forecast
4.2 Volume & Forecast


5. United States Biopsy Share

5.1 Market Share & Forecast
5.2 Volume Share & Forecast


6. Segment – United States Biopsy Market

6.1 Prostate Cancer Biopsy

6.1.1 Market & Forecast
6.1.2 Volume & Forecast

6.2 Breast Cancer Biopsy

6.2.1 Market & Forecast
6.2.2 Volume & Forecast

6.3 Lung Cancer Biopsy

6.3.1 Market & Forecast
6.3.2 Volume & Forecast

6.4 Liver Cancer Biopsy

6.4.1 Market & Forecast
6.4.2 Volume & Forecast

6.5 Thyroid Cancer Biopsy

6.5.1 Market & Forecast
6.5.2 Volume & Forecast

6.6 Kidney Cancer Biopsy

6.6.1 Market & Forecast
6.6.2 Volume & Forecast

6.7 Colon & Rectum Cancer Biopsy

6.7.1 Market & Forecast
6.7.2 Volume & Forecast

6.8 Melanoma Skin Cancer Biopsy

6.8.1 Market & Forecast
6.8.2 Volume & Forecast


7. Company Analysis

7.1 Becton, Dickinson & Company

7.1.1 Overview
7.1.2 Initiatives & Recent Developments
7.1.3 Mergers & Acquisitions
7.1.4 Revenue

7.2 B. Braun Melsungen AG (Germany)

7.2.1 Overview
7.2.2 Initiatives & Recent Developments
7.2.3 Mergers & Acquisitions
7.2.4 Revenue

7.3 Cardinal Health, Inc.

7.3.1 Overview
7.3.2 Initiatives & Recent Developments
7.3.3 Mergers & Acquisitions
7.3.4 Revenue

7.4 Olympus Corporation (Japan)

7.4.1 Overview
7.4.2 Initiatives & Recent Developments
7.4.3 Mergers & Acquisitions
7.4.4 Revenue

7.5 Boston Scientific Corporation (U.S.)

7.5.1 Overview
7.5.2 Initiatives & Recent Developments
7.5.3 Mergers & Acquisitions
7.5.4 Revenue

7.6 Medtronic Plc.

7.6.1 Overview
7.6.2 Initiatives & Recent Developments
7.6.3 Mergers & Acquisitions
7.6.4 Revenue

7.7 Hologic, Inc.

7.7.1 Overview
7.7.2 Initiatives & Recent Developments
7.7.3 Mergers & Acquisitions
7.7.4 Revenue


8. Growth Factors

8.1 Inadequate Screening Tests for Particular Cancers
8.2 Demand for Minimally-Invasive Biopsy Techniques
8.3 Advancement in Biopsy Techniques


9. Challenges

9.1 Reimbursement Issues
9.2 Limitations



List of Figures



Figure-01: United States – Biopsy Market (Million US$), 2010 – 2018
Figure-02: United States - Forecast for Biopsy Market (Million US$), 2019 – 2025
Figure-03: United States – Biopsy Volume (Thousands), 2010 – 2018
Figure-04: United States - Forecast for Biopsy Volume (Thousands), 2019 – 2025
Figure-05: United States – Biopsy Market Share (%), 2010 - 2018
Figure-06: United States - Forecast for Biopsy Market Share (%), 2019 - 2025
Figure-07: United States - Biopsy Volume Share (%), 2010 - 2018
Figure-08: United States - Forecast for Biopsy Volume Share (%), 2019 - 2025
Figure-09: United States – Prostate Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-10: United States - Forecast for Prostate Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-11: United States – Prostate Cancer Biopsy Volume (Thousands), 2010 – 2018
Figure-12: United States - Forecast for Prostate Cancer Biopsy Volume (Thousands), 2019 – 2025
Figure-13: United States – Breast Cancer Biopsy Market (Million US$), 2010 – 2018
Figure-14: United States - Forecast for Breast Cancer Biopsy Market (Million US$), 2019 – 2025
Figure-15: United States – Breast Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-16: United States - Forecast for Breast Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-17: United States - Lung Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-18: United States - Forecast for Lung Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-19: United States - Lung Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-20: United States - Forecast for Lung Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-21: United States - Liver Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-22: United States - Forecast for Liver Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-23: United States - Liver Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-24: United States - Forecast for Liver Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-25: United States - Thyroid Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-26: United States - Forecast for Thyroid Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-27: United States - Thyroid Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-28: United States - Forecast for Thyroid Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-29: United States - Kidney Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-30: United States - Forecast for Kidney Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-31: United States - Kidney Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-32: United States - Forecast for Kidney Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-33: United States – Colon & Rectum Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-34: United States - Forecast for Colon & Rectum Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-35: United States – Colon & Rectum Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-36: United States - Forecast for Colon & Rectum Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-37: United States – Melanoma Skin Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-38: United States - Forecast for Melanoma Skin Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-39: United States – Melanoma Skin Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-40: United States - Forecast for Melanoma Skin Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-41: Becton, Dickinson and Company - Revenue (Million US$), 2010 - 2018
Figure-42: Becton, Dickinson and Company – Forecasted Revenue (Million US$), 2019 - 2025
Figure-43: B. Braun Melsungen AG - Revenue (Million US$), 2011 - 2018
Figure-44: B. Braun Melsungen AG - Forecasted Revenue (Million US$), 2019 - 2025
Figure-45: Cardinal Health, Inc. - Revenue (Billion US$), 2010 - 2018
Figure-46: Cardinal Health, Inc. - Forecasted Revenue (Billion US$), 2019 - 2025
Figure-47: Olympus Corporation - Revenue (Million US$), 2010 - 2018
Figure-48: Olympus Corporation - Forecasted Revenue (Million US$), 2019 - 2025
Figure-49: Boston Scientific Corporation - Revenue (Million US$), 2010 - 2018
Figure-50: Boston Scientific Corporation - Forecasted Revenue (Million US$), 2019 - 2025
Figure-51: Medtronic Plc. - Revenue (Million US$), 2010 - 2018
Figure-52: Medtronic Plc. - Forecasted Revenue (Million US$), 2019 - 2025
Figure-53: Hologic, Inc. - Revenue (Million US$), 2013 - 2018
Figure-54: Hologic, Inc. - Forecasted Revenue (Million US$), 2019 - 2025

 

List of Tables



Table 6?1: New Bundled Codes for Breast Biopsy With Image Guidance
Table 6?2: Breast Biopsy - Final Medicare Physician Fee Schedule, 2015